BACKGROUND: The Rotterdam Study previously found that higher dietary intakes of vitamins E and C related to lower risk of dementia and Alzheimer disease (AD) over 6 years of follow-up. OBJECTIVE: To study consumption of major dietary antioxidants relative to long-term risk of dementia. DESIGN: Population-based prospective cohort study. SETTING: The Rotterdam Study in the Netherlands. PARTICIPANTS: A total of 5395 participants, 55 years and older, who were free of dementia and provided dietary information at study baseline. MAIN OUTCOME MEASURES: Incidence of dementia and AD, based on internationally accepted criteria, relative to dietary intake of vitamin E, vitamin C, beta carotene, and flavonoids. RESULTS: During a mean follow-up period of 9.6 years, dementia developed in 465 participants, of whom 365 were diagnosed as having AD. In multivariate models adjusted for age, education, apolipoprotein E epsilon4 genotype, total energy intake, alcohol intake, smoking habits, body mass index, and supplement use, higher intake of vitamin E at study baseline was associated with lower long-term risk of dementia (P = .02 for trend). Compared with participants in the lowest tertile of vitamin E intake, those in the highest tertile were 25% less likely to develop dementia (hazard ratio, 0.75; 95% confidence interval, 0.59-0.95 with adjustment for potential confounders). Dietary intake levels of vitamin C, beta carotene, and flavonoids were not associated with dementia risk after multivariate adjustment (P > .99 for trend for vitamin C and beta carotene and P = .60 for trend for flavonoids). Results were similar when risk for AD was specifically assessed. CONCLUSION: Higher intake of foods rich in vitamin E may modestly reduce long-term risk of dementia and AD.
BACKGROUND: The Rotterdam Study previously found that higher dietary intakes of vitamins E and C related to lower risk of dementia and Alzheimer disease (AD) over 6 years of follow-up. OBJECTIVE: To study consumption of major dietary antioxidants relative to long-term risk of dementia. DESIGN: Population-based prospective cohort study. SETTING: The Rotterdam Study in the Netherlands. PARTICIPANTS: A total of 5395 participants, 55 years and older, who were free of dementia and provided dietary information at study baseline. MAIN OUTCOME MEASURES: Incidence of dementia and AD, based on internationally accepted criteria, relative to dietary intake of vitamin E, vitamin C, beta carotene, and flavonoids. RESULTS: During a mean follow-up period of 9.6 years, dementia developed in 465 participants, of whom 365 were diagnosed as having AD. In multivariate models adjusted for age, education, apolipoprotein E epsilon4 genotype, total energy intake, alcohol intake, smoking habits, body mass index, and supplement use, higher intake of vitamin E at study baseline was associated with lower long-term risk of dementia (P = .02 for trend). Compared with participants in the lowest tertile of vitamin E intake, those in the highest tertile were 25% less likely to develop dementia (hazard ratio, 0.75; 95% confidence interval, 0.59-0.95 with adjustment for potential confounders). Dietary intake levels of vitamin C, beta carotene, and flavonoids were not associated with dementia risk after multivariate adjustment (P > .99 for trend for vitamin C and beta carotene and P = .60 for trend for flavonoids). Results were similar when risk for AD was specifically assessed. CONCLUSION: Higher intake of foods rich in vitamin E may modestly reduce long-term risk of dementia and AD.
Authors: J A Joseph; B Shukitt-Hale; N A Denisova; D Bielinski; A Martin; J J McEwen; P C Bickford Journal: J Neurosci Date: 1999-09-15 Impact factor: 6.167
Authors: Ronald C Petersen; Ronald G Thomas; Michael Grundman; David Bennett; Rachelle Doody; Steven Ferris; Douglas Galasko; Shelia Jin; Jeffrey Kaye; Allan Levey; Eric Pfeiffer; Mary Sano; Christopher H van Dyck; Leon J Thal Journal: N Engl J Med Date: 2005-04-13 Impact factor: 91.245
Authors: M Sano; C Ernesto; R G Thomas; M R Klauber; K Schafer; M Grundman; P Woodbury; J Growdon; C W Cotman; E Pfeiffer; L S Schneider; L J Thal Journal: N Engl J Med Date: 1997-04-24 Impact factor: 91.245
Authors: K Klipstein-Grobusch; J H den Breeijen; R A Goldbohm; J M Geleijnse; A Hofman; D E Grobbee; J C Witteman Journal: Eur J Clin Nutr Date: 1998-08 Impact factor: 4.016
Authors: J A Joseph; B Shukitt-Hale; N A Denisova; R L Prior; G Cao; A Martin; G Taglialatela; P C Bickford Journal: J Neurosci Date: 1998-10-01 Impact factor: 6.167
Authors: Seithikurippu R Pandi-Perumal; Ahmed S BaHammam; Gregory M Brown; D Warren Spence; Vijay K Bharti; Charanjit Kaur; Rüdiger Hardeland; Daniel P Cardinali Journal: Neurotox Res Date: 2012-06-28 Impact factor: 3.911
Authors: Martha Clare Morris; Julie A Schneider; Hong Li; Christy C Tangney; Sukriti Nag; David A Bennett; William G Honer; Lisa L Barnes Journal: Alzheimers Dement Date: 2014-02-28 Impact factor: 21.566
Authors: Elizabeth E Devore; Edith Feskens; M Arfan Ikram; Tom den Heijer; Meike Vernooij; Fedde van der Lijn; Albert Hofman; Wiro J Niessen; Monique M B Breteler Journal: Neurology Date: 2013-02-20 Impact factor: 9.910